CYBERGUN SA (ALCYB.PA)

FR0014004QR6 - Common Stock

0.0001  0 (0%)

Fundamental Rating

1

ALCYB gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 14 industry peers in the Leisure Products industry. ALCYB has a bad profitability rating. Also its financial health evaluation is rather negative. ALCYB has a expensive valuation and it also scores bad on growth.



Quickly go to:

1

1. Profitability

1.1 Basic Checks

ALCYB had negative earnings in the past year.
ALCYB had a negative operating cash flow in the past year.
ALCYB had negative earnings in 4 of the past 5 years.
In the past 5 years ALCYB always reported negative operating cash flow.

1.2 Ratios

ALCYB has a Return On Assets of -25.18%. This is amonst the worse of the industry: ALCYB underperforms 92.31% of its industry peers.
ALCYB has a worse Return On Equity (-90.14%) than 92.31% of its industry peers.
Industry RankSector Rank
ROA -25.18%
ROE -90.14%
ROIC N/A
ROA(3y)-12.03%
ROA(5y)-24.01%
ROE(3y)-37.16%
ROE(5y)-580.68%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of ALCYB (40.24%) is comparable to the rest of the industry.
ALCYB's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for ALCYB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 40.24%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y15.43%
GM growth 5Y25.11%

More info and screens

2

2. Health

2.1 Basic Checks

ALCYB does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ALCYB has been increased compared to 1 year ago.
ALCYB has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ALCYB has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of -0.12, we must say that ALCYB is in the distress zone and has some risk of bankruptcy.
ALCYB has a worse Altman-Z score (-0.12) than 92.31% of its industry peers.
A Debt/Equity ratio of 0.12 indicates that ALCYB is not too dependend on debt financing.
ALCYB has a better Debt to Equity ratio (0.12) than 84.62% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Altman-Z -0.12
ROIC/WACCN/A
WACC3.51%

2.3 Liquidity

A Current Ratio of 1.13 indicates that ALCYB should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.13, ALCYB is doing worse than 76.92% of the companies in the same industry.
ALCYB has a Quick Ratio of 1.13. This is a bad value and indicates that ALCYB is not financially healthy enough and could expect problems in meeting its short term obligations.
ALCYB has a Quick ratio of 0.49. This is amonst the worse of the industry: ALCYB underperforms 92.31% of its industry peers.
Industry RankSector Rank
Current Ratio 1.13
Quick Ratio 0.49

More info and screens

1

3. Growth

3.1 Past

ALCYB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -3399.84%.
The Revenue has decreased by -1.46% in the past year.
Measured over the past years, ALCYB shows a small growth in Revenue. The Revenue has been growing by 5.94% on average per year.
EPS 1Y (TTM)-3399.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1588.5%
Revenue 1Y (TTM)-1.46%
Revenue growth 3Y1.97%
Revenue growth 5Y5.94%
Sales Q2Q%-29.54%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALCYB. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALCYB!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CYBERGUN SA

EPA:ALCYB (1/3/2025, 7:00:00 PM)

0.0001

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryLeisure Products
Earnings (Last)10-31 2024-10-31
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap122.89K
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0
P/FCF N/A
P/OCF N/A
P/B 0.01
P/tB 0.02
EV/EBITDA N/A
EPS(TTM)-0.2
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0.03
BVpS0.01
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -25.18%
ROE -90.14%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 40.24%
FCFM N/A
ROA(3y)-12.03%
ROA(5y)-24.01%
ROE(3y)-37.16%
ROE(5y)-580.68%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y15.43%
GM growth 5Y25.11%
F-Score4
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 56.56%
Cap/Sales 2.67%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.13
Quick Ratio 0.49
Altman-Z -0.12
F-Score4
WACC3.51%
ROIC/WACCN/A
Cap/Depr(3y)164.05%
Cap/Depr(5y)N/A
Cap/Sales(3y)6.65%
Cap/Sales(5y)5.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3399.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1588.5%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.46%
Revenue growth 3Y1.97%
Revenue growth 5Y5.94%
Sales Q2Q%-29.54%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-495.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y66.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y62.3%
OCF growth 3YN/A
OCF growth 5YN/A